A detailed history of Israel Englander (Millennium Management LLC) transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 5,146,653 shares of BLUE stock, worth $2.52 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,146,653
Previous 6,239,541 17.52%
Holding current value
$2.52 Million
Previous $7.99 Million 36.85%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$0.85 - $1.26 $928,954 - $1.38 Million
-1,092,888 Reduced 17.52%
5,146,653 $5.04 Million
Q1 2024

May 15, 2024

BUY
$0.91 - $1.75 $2.57 Million - $4.95 Million
2,825,929 Added 82.78%
6,239,541 $7.99 Million
Q4 2023

Feb 14, 2024

BUY
$1.32 - $4.83 $4.51 Million - $16.5 Million
3,413,612 New
3,413,612 $4.71 Million
Q1 2023

May 15, 2023

BUY
$3.14 - $8.22 $2.81 Million - $7.37 Million
896,076 Added 123.92%
1,619,161 $5.15 Million
Q4 2022

Feb 14, 2023

SELL
$5.77 - $8.49 $5.33 Million - $7.85 Million
-924,245 Reduced 56.11%
723,085 $5 Million
Q3 2022

Nov 14, 2022

SELL
$3.75 - $7.39 $3.16 Million - $6.22 Million
-841,488 Reduced 33.81%
1,647,330 $10.4 Million
Q2 2022

Aug 15, 2022

BUY
$2.94 - $5.23 $4.6 Million - $8.19 Million
1,566,073 Added 169.72%
2,488,818 $10.3 Million
Q1 2022

May 16, 2022

BUY
$4.07 - $10.6 $1.59 Million - $4.15 Million
391,568 Added 73.72%
922,745 $4.48 Million
Q4 2021

Feb 14, 2022

BUY
$8.96 - $16.31 $2.33 Million - $4.24 Million
259,870 Added 95.78%
531,177 $5.31 Million
Q3 2021

Nov 15, 2021

SELL
$11.24 - $21.0 $1.62 Million - $3.03 Million
-144,056 Reduced 34.68%
271,307 $5.19 Million
Q2 2021

Aug 16, 2021

SELL
$18.04 - $22.09 $470,753 - $576,438
-26,095 Reduced 5.91%
415,363 $13.3 Million
Q1 2021

May 17, 2021

BUY
$16.59 - $33.89 $5.98 Million - $12.2 Million
360,444 Added 444.92%
441,458 $13.3 Million
Q4 2020

Feb 16, 2021

SELL
$27.5 - $37.92 $667,810 - $920,849
-24,284 Reduced 23.06%
81,014 $3.51 Million
Q3 2020

Nov 16, 2020

SELL
$34.44 - $43.75 $3.05 Million - $3.87 Million
-88,527 Reduced 45.67%
105,298 $5.68 Million
Q2 2020

Aug 14, 2020

SELL
$27.12 - $45.97 $7.47 Million - $12.7 Million
-275,522 Reduced 58.7%
193,825 $11.8 Million
Q1 2020

May 14, 2020

BUY
$26.16 - $63.5 $6.03 Million - $14.6 Million
230,515 Added 96.52%
469,347 $21.6 Million
Q4 2019

Feb 14, 2020

BUY
$46.96 - $61.67 $7.88 Million - $10.3 Million
167,795 Added 236.21%
238,832 $21 Million
Q3 2019

Nov 14, 2019

SELL
$59.47 - $93.1 $741,828 - $1.16 Million
-12,474 Reduced 14.94%
71,037 $6.52 Million
Q2 2019

Aug 15, 2019

SELL
$75.84 - $105.21 $12.5 Million - $17.4 Million
-165,423 Reduced 66.45%
83,511 $10.6 Million
Q2 2019

Aug 14, 2019

BUY
$75.84 - $105.21 $8.51 Million - $11.8 Million
112,154 Added 82.0%
248,934 $13.3 Million
Q1 2019

May 14, 2019

BUY
$64.44 - $104.11 $115,540 - $186,669
1,793 Added 1.33%
136,780 $21.5 Million
Q4 2018

Feb 14, 2019

BUY
$59.1 - $93.26 $3.37 Million - $5.32 Million
57,055 Added 73.21%
134,987 $13.4 Million
Q3 2018

Nov 14, 2018

SELL
$88.86 - $117.49 $32.8 Million - $43.3 Million
-368,616 Reduced 82.55%
77,932 $11.4 Million
Q2 2018

Aug 14, 2018

BUY
$99.64 - $127.59 $44.5 Million - $57 Million
446,548 New
446,548 $70.1 Million
Q1 2018

May 15, 2018

SELL
$105.8 - $150.94 $1.55 Million - $2.21 Million
-14,670 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$81.25 - $130.7 $1.19 Million - $1.92 Million
14,670
14,670 $2.61 Million

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $37.8M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.